The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof. The compounds are inhibitors of ERK 1/2 kinases and will be useful in the treatment of ERKl/2-mediated conditions. The compounds are therefore useful in therapy, in particular in the treatment of cancer.
该发明提供了一个化合物,其
化学式为(0):或其药学上可接受的盐、N-
氧化物或互变异构体。这些化合物是ERK 1/2激酶的
抑制剂,并将在治疗ERKl/2介导的疾病中发挥作用。因此,这些化合物在治疗中特别是在癌症治疗中是有用的。